EFFECTS OF THE ORAL ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR MK-421 IN HUMAN HYPERTENSION

被引：16
作者：
GAVRAS, H
BIOLLAZ, J
WAEBER, B
BRUNNER, HR
GAVRAS, I
SACKEL, H
CHAROCOPOS, F
DAVIES, RO
机构：
[1] BOSTON UNIV,BOSTON CITY HOSP,MED CTR,DEPT MED,THORNDIKE MEM LABS,BOSTON,MA 02118
[2] CHU LAUSANNE,LAUSANNE,SWITZERLAND
[3] MERCK SHARP & DOHME,W POINT,PA 19486
来源：
CLINICAL SCIENCE | 1981年 / 61卷
关键词：
D O I：
10.1042/cs061281s
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：S281 / S283
页数：3
相关论文
共 13 条
[1]   INTERRUPTION OF THE RENIN-ANGIOTENSIN SYSTEM IN HYPERTENSIVE PATIENTS BY CAPTOPRIL INDUCES SUSTAINED REDUCTION IN ALDOSTERONE SECRETION, POTASSIUM RETENTION AND NATRIURESIS [J].
ATLAS, SA ;
CASE, DB ;
SEALEY, JE ;
LARAGH, JH ;
MCKINSTRY, DN .
HYPERTENSION, 1979, 1 (03) :274-280
[2]   CONVERTING ENZYME-INHIBITION WITH AN ORALLY ACTIVE COMPOUND IN HYPERTENSIVE MAN [J].
BRAVO, EL ;
TARAZI, RC .
HYPERTENSION, 1979, 1 (01) :39-46
[3]   ORAL ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR IN LONG-TERM TREATMENT OF HYPERTENSIVE PATIENTS [J].
BRUNNER, HR ;
GAVRAS, H ;
WAEBER, B ;
KERSHAW, GR ;
TURINI, GA ;
VUKOVICH, RA ;
MCKINSTRY, DN ;
GAVRAS, I .
ANNALS OF INTERNAL MEDICINE, 1979, 90 (01) :19-23
[4]   SPECTROPHOTOMETRIC ASSAY AND PROPERTIES OF ANGIOTENSIN-CONVERTING ENZYME OF RABBIT LUNG [J].
CUSHMAN, DW ;
CHEUNG, HS .
BIOCHEMICAL PHARMACOLOGY, 1971, 20 (07) :1637-+
[5]   ESTIMATION OF ANGIOTENSIN II CONCENTRATION IN HUMAN PLASMA BY RADIOIMMUNOASSAY - SOME APPLICATIONS TO PHYSIOLOGICAL AND CLINICAL STATES [J].
DUSTERDIECK, G ;
MCELWEE, G .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1971, 2 (01) :32-+
[6]   ANTIHYPERTENSIVE EFFECT OF ORAL ANGIOTENSIN CONVERTING-ENZYME INHIBITOR SQ 14225 IN MAN [J].
GAVRAS, H ;
BRUNNER, HR ;
TURINI, GA ;
KERSHAW, GR ;
TIFFT, CP ;
CUTTELOD, S ;
GAVRAS, I ;
VUKOVICH, RA ;
MCKINSTRY, DN .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 298 (18) :991-995
[7]   FATAL PANCYTOPENIA ASSOCIATED WITH THE USE OF CAPTOPRIL [J].
GAVRAS, I ;
GRAFF, LG ;
ROSE, BD ;
MCKENNA, JM ;
BRUNNER, HR ;
GAVRAS, H .
ANNALS OF INTERNAL MEDICINE, 1981, 94 (01) :58-59
[8]  
GROSS DM, 1981, J PHARM EXPT THERAPE
[9]  
PATCHETT AA, 1980, NATURE, V288, P280, DOI 10.1038/288280a0
[10]  
PRINS EJL, 1979, LANCET, V2, P306
12